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Background Robust replication is a sine qua non for the rigorous documentation of proposed associations in the genome-wide association (GWA) setting. Currently, associations of common variants reaching P 4 5 Â 10 À8 are considered replicated. However, there is some ambiguity about the most suitable threshold for claiming genome-wide significance.
Methods
We defined as 'borderline' associations those with P > 5 Â 10 À8 and P 41 Â 10 À7 . The eligible associations were retrieved using the 'Catalog of Published Genome-Wide Association Studies'. For each association we assessed whether it reached P 4 5 Â 10 À8 with inclusion of additional data from subsequent GWA studies.
Results
Thirty-four eligible genotype-phenotype associations were evaluated with data and clarifications contributed from diverse investigators. Replication data from subsequent GWA studies could be obtained for 26 of them. Of those, 19 associations (73%) reached P 4 5 Â 10 À8 for the same or a related trait implicating either the exact same allele or one in very high linkage disequilibrium and 17 reached P < 10 À8 . If the seven associations that did not reach P 4 5 Â 10 À8 when additional data were considered are assumed to have been false-positives, the false-discovery rate for borderline associations is estimated to be 27% [95% confidence interval (CI) 12-48%]. For five associations, the current P-value is > 10 Introduction Genome-wide association (GWA) studies have so far yielded a large number of associations between single-nucleotide polymorphisms (SNPs) and complex diseases or physiological traits. 1 To date, about 4000 putative SNP-phenotype associations have been proposed by more than 700 GWA studies using a lenient cut-off value of P < 10 À5 , which has been used by the National Human Genome Research Institute for the identification and archiving of putative associations. 2 However, not all of them are genuine. 3 About 1000 of these associations have exceedingly low P-values and can be considered definitively true, whereas many others have modest P-values and only a small fraction of them is likely to be true. Robust replication is a sine qua non for the rigorous documentation of proposed associations in the GWA setting 4 and typically this is accomplished with meta-analysis of GWA studies and subsequent replication efforts [5] [6] [7] [8] until a threshold of genome-wide significance (GWS) is achieved.
The selection of the most suitable GWS threshold has some uncertainty in the current literature. The GWS should account for the multiplicity of comparisons that are performed as part of the massive testing in a GWA study; [9] [10] [11] this burden of multiple testing constitutes a major challenge for GWA studies. 12 A variety of statistical approaches accounting for multiple testing in the genome-wide setting have been developed, 13 including statistical independence methods; 14 methods for adjusting the error rate, such as Bonferroni correction, 15 Sidak correction, 16 false discovery rate, 10 weighted multiple hypothesis testing; 17 and data reduction methods. 18 At a practical level, some early GWA studies used a threshold of P 4 10 À7 , [19] [20] [21] but the current practice seems to prefer routinely a threshold of P 4 5 Â 10 À8 . [22] [23] [24] [25] Other thresholds have been employed less frequently [e.g. P 4 5 Â 10 À7 ]. 26 With an increasing burden of tests (e.g. 1000 genome imputation or full genome sequencing), one may argue that even more stringent thresholds may be required. Moreover, none of these thresholds is absolute. It has been postulated-and examined with theoretical arguments and simulations-that the most suitable GWS may vary for different populations, different SNPs with different minor allele frequencies and different linkage disequilibrium patterns (non-independence of markers constitutes a major source of uncertainty about this threshold), and different arrays, as well as for different type of genetic data (dense SNP vs sequencing data). [27] [28] [29] [30] The GWS threshold for samples of European ancestry may be substantially higher than for African samples, 31 where the lower linkage disequilibrium increases the effective number of hypotheses tested. Moreover, GWS levels are different when genome-wide interaction analyses are performed. 32 Given this ambiguity, as a general rule, currently associations of common variants reaching significance levels of P 4 5 Â 10 À8 are considered replicated, 28 whereas those with P 5 1 Â 10 À7 generally are not accepted as proven until more rigorous replication has been achieved. These cut-offs are based on the estimated effective number of independent tests in the genome if all common SNPs in HapMap were tested with direct genotyping or imputation, i.e. $10 6 tests, at the a ¼ 0.05 level. 28, 31, 33 It remains unclear to what extent associations lying in the grey zone of P-values of 5 Â 10 À8 to 1 Â 10 À7 are genuine. Besides theoretical arguments and simulations, one can use the accumulated experience from GWA studies to answer this question empirically. Thus, here we isolated associations proposed by GWA studies with P-values between 5 Â 10 À8 and 1 Â 10 À7 and examined whether they had been robustly replicated by subsequent studies.
Materials and Methods
We screened the online database 'A Catalog of Published Genome-Wide Association Studies' (referred to here as GWAS Catalogue) 2 hosted by the National Human Genome Research Institute, Office of Population Genetics. This catalogue lists SNP-trait associations with statistical significance levels of P < 10 À5 extracted from published GWA studies that attempt to assay 100 000 SNPs or more. 34 We defined as eligible associations those with P > 5 Â 10 À8 and P 4 1 Â 10 À7 , henceforth called borderline associations. The GWAS catalogue lists only the most statistically significant SNP, when there are many highly-linked, non-independent SNPs in the same locus. We focused on SNPs, excluding haplotypes thereof and copy-number variants (CNVs). We also excluded associations for which the same genephenotype association had been examined in at least one concurrently and/or previously published GWA investigation that had reached P 4 5 Â 10
À8
. Moreover, we only considered SNP-trait associations including data from only one of the three major ancestry groups (European, Asian, African) and excluded those derived from mixing populations from two or more of these ancestry groups. When data were provided to calculate P-values in single ancestry groups or mixing several ancestry groups, the former were selected.
For the remaining borderline associations, we searched the GWAS Catalogue for other GWA studies conducted on the same phenotype that had been published subsequently to the one that first proposed the borderline association. Borderline associations for which no other GWA studies on the same phenotype were identified were excluded. We did not consider those borderline associations for which all other GWA studies on the same phenotype were either previously or concurrently published, since it is possible that reporting of a borderline association in these cases may have been influenced by knowledge of the results of previous or concurrent GWA studies being also supportive; this could have inflated the replication rate for borderline associations. Moreover, we did not consider subsequent GWA studies that were conducted on populations of different ancestry than those where the borderline associations had been discovered. If no subsequent GWA study existed on a population of same ancestry (European, Asian, African), then the respective borderline association was excluded from further analysis.
For each of the remaining borderline associations, we scrutinized the subsequent GWA studies whether they reported any data on the same SNP or a different SNP that was either in full or very high linkage disequilibrium (LD) (r 2 5 0.85) with the one implicated in the borderline association. If the borderline association had reached P 4 5 Â 10 À8 in at least one subsequent GWA study, it was considered replicated. Otherwise, replication status was determined after performing meta-analysis by combining the results of each borderline association with those of the subsequent GWA studies on the same SNP, whenever data were available in the published reports and supplements of the subsequent GWA studies. Meta-analyses were performed even for cases where a borderline association had reached P 4 5 Â 10 À8 in a subsequent study so as to obtain eventually a summary P-value including all evidence for each association. Meta-analysis used fixed-effect synthesis of the effect sizes and variances making sure the allele coding is standardized in all data. 35, 36 Fixed-effect meta-analysis is more efficient than random effects when the purpose is to maximize power to rejecting the null hypothesis that all data sets have effects equal to the null. 37 When only P-values were given without effect size, we combined the z-scores of the P-values using the Fisher's method 36, 38 -in all cases where P-values were synthesized, all data sets had effects for the same allele in the same direction. Meta-analysis methods combining P-values give very similar results for the summary P-value, as fixedeffect approaches. 39 In all meta-analyses we ensured that no overlapping data were combined; when data overlapped between two GWA publications, only the largest sample was retained. We then considered as replicated those associations for which the combined effect of all the available data reached P 4 5 Â 10 À8 in the respective meta-analysis.
For those associations where this P-value was not reached, but not all subsequent GWA studies had available data in their published papers and supplements, we communicated with investigators of the subsequent studies and asked them to contribute to our replication process by providing information on the effect size, variance, P-value and direction of effect for each SNP-trait association of interest. When several such subsequent GWA studies existed, we contacted first the investigators of the GWA study with the largest sample size in the discovery stage; if the addition of these data did not result in P 4 5 Â 10 À8 or the investigators did not reply, we contacted serially the investigators of smaller GWA studies, until the combined data reached
À8 or all investigators with potential GWA data for the respective borderline SNP-trait association had been contacted. Contacted investigators who contributed data and/or clarifications were also asked to review the complied database and manuscript.
Additionally, for each eligible borderline association we recorded whether it was first proposed by a GWA study done on a single population; by a GWA study done on a single population with additional replication of specific SNPs in one or many other populations; by a meta-analysis of many GWA studies on several populations; or by a meta-analysis of many GWA studies on several populations plus replication of specific SNPs in additional population(s). We also recorded which of the SNPs implicated in these associations were directly genotyped in the respective studies; imputed from the HapMap data; or imputed based on the 1000 Genomes data.
The search for eligible borderline associations in the GWAS Catalogue was last updated on 17 July 2010. For subsequent eligible GWA studies on the same SNP-trait association, the last search was performed on 10 December 2010. Statistical analyses were performed in STATA 40 (College Station, TX, USA), version 10.1, using the metan and metap commands for fixed-effects meta-analysis and meta-analysis of P-values, respectively. Linkage disequilibrium patterns were identified using the HapMap Phases 2 and 3 data on the respective ancestry population, as these were retrieved by the 'SNP Annotation and Proxy Search (SNAP)' tool version 2.2 (available at http://www. broadinstitute.org/mpg/snap/), Broad Institute, MA, USA. 41 All P-values are two-tailed.
Results

Eligible borderline associations
Up to 17 July 2010, the GWAS Catalogue listed 147 SNP-disease associations with P 4 10 À7 and P > 5 Â 10 À8 . Of those, we excluded 38 associations, for which the same gene locus-phenotype association had been examined in at least one concurrent and/or previous GWA study reaching P 4 5 Â 10 À8 . For the remaining 109 associations with borderline significance, we searched the GWAS Catalogue for subsequent GWA studies on the same phenotype. No subsequent GWA study was found for the phenotype of 47 borderline associations. Moreover, two associations were excluded, because the borderline significance referred to populations of mixed ancestry without any data on single ancestry groups being available. Of the remaining 60 associations, we excluded 23, because all the subsequent GWA studies had been conducted on populations of different ancestry. One other association (rs13266634-C and type 2 diabetes) was reported by four different GWA studies with P 4 1 Â 10 À7 and P > 5 Â 10 À8 in each of them; thus we included as eligible the earliest published GWA study, 42 and considered the other three [43] [44] [45] as subsequent replications. Overall, 34 SNP-trait borderline associations were eligible. These associations implicated a total of 33 different variants and pertained to 24 different phenotypes [height (n ¼ 7 associations), 46 -48 bipolar disorder (n ¼ 2), 26, 49 celiac disease (n ¼ 2), 50 hair morphology (n ¼ 2), 51 non-syndromic cleft lip with or without cleft palate (n ¼ 2), 52, 53 as well as one association for amyotrophic lateral sclerosis, 54 attention deficit hyperactivity disorder, 55 ]. As shown in Table 1 , 33 borderline associations had been proposed in European ancestry populations, and 1 had been proposed in Asian ancestry populations. The median minor allele frequency was 30% [interquartile range (IQR) 23-38%, range 3-48%] and only one association had minor allele frequency 45%. The median risk allele frequency was 39% (IQR 33-71%, range 7-97%). Effect size estimates were retrievable for a total of 20 borderline associations. For the 15 associations with binary phenotypes, the median per risk allele odds ratio (OR) was 1.30 (IQR 1.20-1.57). For each eligible borderline association a median of four subsequent GWA studies (IQR 2-7) on the same ancestry groups were identified. A total of 28 SNPs were directly genotyped in the respective studies, whereas the remaining were imputed based on the HapMap data.
Replication based on published data Based on published data, a total of 13 borderline associations turned out to reach P 4 5 Â 10
À8
, either in at least one subsequent GWA study (n ¼ 6 replicated associations of which one replication implicated a SNP in full LD with the borderline one), or from meta-analysis (n ¼ 7 replicated associations) based on the data available in the published full-texts and/ or supplements of subsequent GWA studies.
One association (rs10260404-C and amyotrophic lateral sclerosis) did not reach the GWS threshold in the largest subsequent GWA study (P ¼ 1.50 Â 10 À3 ) that included data from all previous GWA studies on the same trait, including the data from the GWA study reporting the borderline association.
Replication based on additional retrieved data from investigators
For the other 20 associations, we tried to obtain data from investigators of the subsequent GWA studies with the largest sample size in the discovery stage. This includes three associations, where the meta-analysis of the available published data did not reach P 4 5 Â 10 À8 but more data were seemingly available, and 17 associations where no information on the SNPs of interest was reported in any of the subsequent published GWA studies.
After assessing the additional data received from investigators, another five associations reached P 4 5 Â 10 À8 for the same phenotype. Of those, one association (rs13437082-A and height) reached P 4 5 Â 10 À8 in the respective subsequent GWA study, and the other four passed this GWS threshold in meta-analysis of the data from the original and subsequent GWA studies [non-syndromic cleft lip/ rs7590268-G, type 1 diabetes/rs3764021-C, hair morphology/rs1268789-T using data on the same SNP; and hair morphology/rs6732426-T using data on the highly-linked rs3901678-G (r 2 ¼ 0.85) in the subsequent GWA study]. One more association (rs10146997-G and waist circumference unadjusted for body mass index) reached P 4 5 Â 10 À8 for a correlated trait (body mass index; correlation coefficient with waist circumference $0.90) in a subsequent study through full LD (r 2 ¼ 1) with the probed rs10150332.
A total of six associations did not reach P 4 5 Â 10 À8 , when the additional data were considered. Four associations (LDL cholesterol and rs2254287-G; height and rs11809207-A and rs10935120-A; rs1678542-C and rheumatoid arthritis) did not reach this threshold in the respective largest subsequent GWA study [71] [72] [73] which included also the previous GWA data that had proposed the borderline association. Another two associations did not reach this P-value threshold after meta-analysis of the available data (rs13208776-A and vitiligo, rs17115100-G and Parkinson's disease).
Moreover, one SNP (rs189897-A associated with nasopharyngeal carcinoma) was not captured in the platform used in one of the two subsequent GWA studies on the same disease; 74 neither was it included in the second subsequent study 75 , because an SNP in the same locus (r 2 ¼ 0.44) that had previously been reported as GWS 60 was no longer statistically significant (P ¼ 0.48).
Finally, for seven associations (attention deficit hyperactivity disorder and rs11243897; bipolar disorder and rs420259-A; breast cancer and rs2075555; mean corpuscular haemoglobin and rs1397048-T; pancreatic cancer and rs505922-C; schizophrenia and rs9272219-G; weight and rs12517906-G), we could not obtain any additional data from the investigators. For these SNPs, the risk alleles and the respective allele frequencies could not be retrieved in the published GWA studies.
c For these borderline associations the respective effect estimates could not be retrieved from the published GWA studies.
d For these SNPs, the risk allele frequencies were retrieved from the International HapMap Phase 3 data, because they were not available in the published GWA studies.
e The gene locus for rs3764021 was not reported by the authors of the borderline GWAS and this information was retrieved using NCBI dbSNP database. Table 2 shows the current replication status of the 26 assessed borderline associations for which we could obtain data either from published reports or directly from investigators. The median risk allele frequency for these associations was 38%. Similarly, for 15 associations for which effect estimate data were available the median OR was 1.22. Four of the 26 associations were first proposed by a GWA study performed on a single population; 5 were proposed by a GWA study done on a single population followed by replication in another population; 8 were identified by meta-analysis of many GWA studies on several populations; and 9 were discovered by meta-analysis of many GWA studies and additional replication samples. For 20 of the 26 (77%) associations, the respective SNPs were directly genotyped, whereas for the remaining 6, they were imputed from HapMap. Nineteen associations (73%) have reached P 4 5 Â 10 À8 for the same trait (n ¼ 18) or a correlated trait (n ¼ 1). This includes 8 of the 9 borderline associations proposed by a single GWA study with or without replication samples and 11 of the 17 borderline associations generated from meta-analyses of more than one GWA study. For 15 associations reaching P 4 5 Â 10
Synopsis of current replication status
À8
, the implicated SNPs were among the 20 directly genotyped ones (75%), whereas 4 were among the 6 (67%) imputed from HapMap. The meta-analysis of all non-overlapping data shows that the current P-values range from 1.50 Â 10 À8 to 7.60 Â 10
À34
. Seventeen of the 19 have actually reached P < 10 À8 . It is possible that most, if not all, of these associations are genuine.
Conversely, seven associations have not reached P 4 5 Â 10 À8 and for five of them the current Pvalue is > 10 À6 (the other two are 2.60 Â 10 À7 and 9.10 Â 10 À8 ). It is very likely that at least these five among these borderline associations do not represent genuine signals, since in hundreds of GWA studies to-date, very few of the associations with P > 10 À6 get replicated eventually. The corresponding falsediscovery rate (FDR) is 19% [95% confidence interval (CI) 7-39%] or 27% (95% CI 12-48%), depending on whether five or seven associations are considered non-replicated.
Of the 12 borderline associations that had risk allele frequency <38%, 8 had reached P 4 5 Â 10 À8 [FDR 33% (95% CI 10-65%)]; of the 14 associations with risk allele frequency of 538%, 11 had reached P 4 5 Â 10 À8 [FDR 21% (95% CI 5-51%)]. Of the seven associations whose effect size estimate was <1.22, five had reached P 4 5 Â 10 À8 [FDR 29% (95% CI 4-71%)]; of the eight associations whose effect size estimate was of 51.22, all but one had reached P 4 5 Â 10 À8 [FDR 13% (95% CI 0.3-53%)]. The associations that reached P 4 5 Â 10 À8 did not differ beyond chance in minor allele frequencies, risk allele frequencies or effect size from those that did not reach this threshold (Table 1) .
Discussion
In this analysis, we have examined whether associations with borderline GWS (i.e. P > 5 Â 10 À8 and P 410 À7 ) are successfully replicated in subsequent GWA studies conducted on populations of the same ancestry. Our results show that 73% of those borderline associations reach P 4 5 Â 10 À8 and most of them reach even substantially lower P-values when additional data are obtained. Usually, these are borderline associations first proposed by meta-analyses of GWA studies on many populations with accompanying replication efforts. Most, if not all, of these associations are possibly genuine and have modest to high credibility. The remaining associations account for an FDR of 27% (95% CI 12-48%), and, of those, we cannot exclude the possibility that some may still become more robustly replicated, if further data were to accrue in the future. However, the credibility of most of them is probably low; this applies in particular to the 5 of the 26 assessed associations where the current P > 10 À6 , which results in an FDR estimate of 19% (95% CI 7-39%). Extensive empirical data from many GWA studies suggest that only a tiny fraction of such P-values reach levels of robust significance, when replication efforts are made. The FDR was not substantially different for the various subgroups based on the median allele frequency and effect size.
It has been argued 76 that associations with borderline significance have low power for replication in subsequent studies. These replication failures may thus be 'pseudo-failures'. Stringent replication (passing GWS in the replication data, excluding any original data that proposed the association) may not be achieved for some associations, even with very large studies. 4 Instead, one may view replication as an ongoing, continuous process where the summary results are recalculated as more data are obtained from each association. This goal can be accomplished by large consortia and/or meta-analyses of the available data 36, 77, 78 and this practice has increased substantially the efficiency of GWA studies. This is also the approach that we followed in this empirical evaluation, where we depended on accumulation of evidence in GWA meta-analyses.
The selection of the suitable genome-wide significance threshold also depends on the relative cost of false-positives against the benefit of decreasing false-negatives. An FDR of 20% suggests that four false-negatives will be eliminated at a cost of one more false-positive. For an FDR of 30%, the ratio is only 2.3, while for an FDR ¼ 48%, the ratio is about 1. Thus if false-positives are considered to have grave consequences, e.g. leading to extensive wasted effort and money in further research trying to understand the function and biology behind the Table 2 The 26 associations where some replication has been attempted Disease/trait 
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Meta-analysis of many GWA studies and the corresponding replication sample(s) (Directly genotyped) GENOME-WIDE SIGNIFICANCE THRESHOLD spurious association, the cost of false-positives may be substantial.
In past GWA practice, the threshold for selecting promising variants for further replication has been usually much less stringent than P ¼ 10 À7 (e.g. in the range of 10 À6 ), because several genuine associations may have very modest P-values in the original discovery GWA samples. Financial constraints in the past may have dictated to a large extent the threshold for pursuing further replication, but this should not be confused with the threshold where one feels confident that an association is genuine. In the current era, we are moving increasingly towards meta-analysis of all available GWA data, which come either from public repositories 79, 80 or from collaborative activities. 78 This is in contrast with the past budget-driven GWA efforts where GWS thresholds were tailored to step-wise approaches where further replication was pursued for limited sets of SNPs. When all available samples for a specific phenotype have been studied in GWA studies and meta-analyses thereof, it may be difficult to draw the line to acknowledge the end of 'real' signals. In the absence of the potential for further replication, our empirical data may offer some guidance of the likely credibility for associations that reach values in the 10 À7 range. Sequencing of regions of interest or whole-genome sequencing 81, 82 may help identify functional, 'causative' variants in some cases and discriminate these variants from random noise and linked markers. 83 However, whole genome sequencing also imposes an extra burden of multiplicity and thus acceptable P-value thresholds may need to become even more stringent in such settings.
Lack of replication in genetic association studies had been notoriously common in the candidate-gene era. 84 The problem persists also to a lesser extent in the GWA era, especially for variants that are proposed to have been discovered with very lenient P-value thresholds. False-positives due to type I error may be the most likely explanation. However, alternative explanations could include the presence of genegene 85 and gene-environment interactions, 86 differential linkage of the proposed markers with the culprit causative variants (including low-frequency variants) that may not be well captured, 87 as well as genuine differences between the studied populations. 45 Some non-replications may be false-negatives. This is a particular concern in the GWA era, where it is widely understood that for the most part the pursued genetic effects are very modest and thus the power to reach very stringent levels of significance is often very limited, even with large studies. 45, 88, 89 In fact, the use of stringent P-value thresholds has resulted currently in a situation where in the typical GWA study or even meta-analysis of several GWA studies the false-negatives far outnumber the false-positives and most genuine markers fail to pass the GWS threshold. 90, 91 Our empirical evaluation suggests that lowering the requested level of significance from 5 Â 10 À8 to 10 À7 would yield mostly true discoveries. Our study has certain limitations. First, most borderline associations did not have any subsequent GWA studies and were thus excluded from our analysis. This selectivity filter curtailed the number of available borderline associations that could be assessed. Moreover, the borderline associations evaluated here are those that were published in the literature, while some others may have remained unpublished due to publication bias. The magnitude of publication bias in the GWA literature is unknown. Publication bias is probably not extensive for variants with P-values between 10 À7 and 5 Â 10 À8 , since such results would be considered highly promising and noteworthy among most investigators and journals. However, it is possible that some borderline associations with such P-values are further tested for replication, and when the associations are not replicated and the P-values become less promising, e.g. 10 À6 or 10 À5 , the chances of publication decrease. If this is so, the proportion of replicated borderline associations may be over-estimated in our study and the FDR may be under-estimated. Further replication is warranted for these putative associations. Secondly, for a minority of the eligible associations additional data could not be retrieved from the subsequent GWA studies. However, most investigators were willing to share the relevant information. The fact that the number of associations included in the final analysis is smaller than the number initially considered highlights the importance and usefulness of making full data from GWA studies publicly available. 92, 93 Thirdly, we did not address here the evolution and between-data set heterogeneity of the effect sizes of proposed borderline associations. Data on effect sizes were not routinely available and we often depended on P-values for data synthesis. Most of the borderline associations' effect sizes seemed small anyhow. True effects, even for those that are replicated, are probably even smaller. Early inflation of effect sizes is a common issue in genetic epidemiology. [94] [95] [96] This 'winner's curse' phenomenon affects also GWA studies. [97] [98] [99] Finally, all the variants that we considered here were common ones. It is unknown whether similar inferences could be made for uncommon and rare variants that may be increasingly the focus of whole genome sequencing [100] [101] [102] and which are more likely to be population-specific.
Acknowledging these caveats, our empirical data suggest that a substantial fraction of the borderline genome-wide significant associations may represent replicable, genuine associations. Given that for many phenotypes the maximum available sample size does not suffice for reaching stringent genome-wide significance criteria for the large majority of loci, our findings can be informative about the consequences of relaxing the discovery criteria to a P ¼ 10 À7 threshold. The FDR for associations with P-value between À7 and 5 Â 10 À8 is probably in the range of 19-27%, but 95% CIs suggest that values up to 48% are possible and high FDR values may need to be anticipated in the presence of publication biases in this literature.
